N. Le-Lindqwister

发表

A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I

N. Staff, C. Loprinzi, K. Ruddy, 2017, Supportive Care in Cancer.

Significant and durable clinical benefit from trastuzumab in 2 patients with HER2‐amplified salivary gland cancer and a review of the literature

V. Miller, R. Erlich, Siraj M. Ali, 2017, Head & neck.

Oral Cancer Chemotherapy Adherence and Adherence Assessment Tools: a Report from North Central Cancer Group Trial N0747 and a Systematic Review of the Literature

B. Costello, N. Foster, A. Jatoi, 2013, Journal of Cancer Education.

Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy

P. Novotny, J. Sloan, C. Loprinzi, 2012, Cancer.

Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

P. Novotny, J. Sloan, C. Loprinzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

Thomas J. Smith, P. Novotny, R. Leon-Ferre, 2019, JNCI cancer spectrum.

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.

M. Burotto, L. Fallowfield, S. Margolin, 2021, European journal of cancer.

Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing

S. Ramsey, W. Barlow, G. Lyman, 2022, JAMA network open.

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

R. Hurt, P. Novotny, J. Sloan, 2007, Mayo Clinic proceedings.

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

C. Shapiro, C. Fadul, E. Paskett, 2013, JAMA.

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).

W. Gradishar, G. Sledge, J. Sparano, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU RU221408I.

C. Loprinzi, K. Ruddy, W. Sikov, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequencing of Charcot–Marie–Tooth disease genes in a toxic polyneuropathy

T. Therneau, G. Schroth, S. Züchner, 2014, Annals of neurology.

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

J. Sloan, D. Moore, C. Loprinzi, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes

Thomas J. Smith, C. Loprinzi, S. Dakhil, 2015, Menopause.

Predictors of duloxetine response in patients with oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601

C. Shapiro, C. Loprinzi, C. Fadul, 2017, European journal of cancer care.

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer.

D W Hillman, E. Perez, A. Dueck, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1

T. Therneau, C. Loprinzi, K. Ruddy, 2015, Acta oncologica.

A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia

S. Ramsey, W. Barlow, S. Sullivan, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).

E. Perez, W. McCaskill-Stevens, J. Sloan, 2014 .

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

C. Shapiro, C. Fadul, E. Paskett, 2013, JAMA.